z-logo
open-access-imgOpen Access
Opposite effects of HDAC5 and p300 on MRTF-A-related neuronal apoptosis during ischemia/reperfusion injury in rats
Author(s) -
Na Li,
Qiong Yuan,
Xiaolu Cao,
Ying Zhang,
Min Zhou,
Shunqing Xu,
Zhijun Yu,
Jun Cheng,
Chunxiang Zhang,
Xingjian Hu
Publication year - 2017
Publication title -
cell death and disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.482
H-Index - 111
ISSN - 2041-4889
DOI - 10.1038/cddis.2017.16
Subject(s) - histone deacetylase 5 , apoptosis , transcription factor , histone deacetylase , histone acetyltransferase , biology , downregulation and upregulation , histone , ischemia , microbiology and biotechnology , cancer research , neuroscience , medicine , biochemistry , gene
Our recent study has revealed that the myocardin-related transcription factor-A (MRTF-A) is involved in the apoptosis of cortical neurons induced by ischemia/reperfusion (I/R). Histone deacetylase 5 (HDAC5) and histone acetyltransferase p300 (P300) are two well-known regulators for transcription factors; however, their roles in MRTF-A-related effect on neuronal injuries during I/R are still unclear. In this study, in a model rat cerebral I/R injury via middle cerebral artery occlusion and reperfusion, we found that the expression and activity of HDAC5 was upregulated, whereas p300 and MRTF-A were downregulated both in expression and activity during I/R. Their expression changes and the interaction of the MRTF-A with HDAC5 or p300 were further verified by double immunofluorescence and co-immunoprecipitation. In cultured neuronal apoptosis model induced by H 2 O 2 , MRTF-A exhibited an anti-apoptotic effect by enhancing the transcription of Bcl-2 and Mcl-1 via CArG box binding. MRTF-A-induced anti-apoptotic effect was effectively inhibited by HDAC5, but was significantly enhanced by p300. The results suggest that both HDAC5 and p300 are involved in MRTF-A-mediated effect on neuronal apoptosis during ischemia/reperfusion injury, but with opposite effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here